Monday, March 17, 2025 | 09:02 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Lockdown-hit corn starch makers find silver lining in downstream pharma

Although pharma accounts for 10-15% of corn starch supplies, manufacturers are looking to partly make up for loss in production, as offtake has received some support from the crash in input corn price

Migrants undergo thermal screening at Lalgarh Junction before they board a special train to their native place Madhubani (Bihar), during the ongoing COVID-19 lockdown, in Bikaner
Premium

Migrants undergo thermal screening at Lalgarh Junction before they board a special train to their native place Madhubani (Bihar), during the ongoing COVID-19 lockdown, in Bikaner

Virendra Singh Rawat Lucknow
The domestic corn starch industry, whose capacity utilisation is down by nearly 50 per cent owing to the covid-19 lockdown, has found a silver lining in the downstream pharmaceutical space, which is among the sectors largely insulated from the pandemic crisis.

Although pharmaceuticals account for 10-15 per cent of corn starch supplies, manufacturers are looking to partly make up for the loss in production, as offtake has received some support from the crash in the input corn prices owing to the bumper crop this season.


Corn starch

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in